ArticleThe Lancet. Oncology2018
Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin era.
Umberto Vitolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2018
Umberto Vitolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.